Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Heart Failure

Free Subscription 06.10.2025 2 Am Heart J 7 Am J Cardiol 2 Ann Thorac Surg 2 Cardiovasc Res 3 Circ Res 2 Circulation 1 Eur Heart J 10 Eur J Heart Fail 2 Int J Cardiol 2 J Am Coll Cardiol 8 J Card Fail 1 J Thorac Cardiovasc Surg 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. MATSUMOTO S, Nasu T, Fujimoto W, Kagiyama N, et al
   Vericiguat and hypotension in patients with heart failure and reduced ejection fraction: VERIFY-HF registry.
   Am Heart J. 2025 Sep 22:S0002-8703(25)00335-7. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   
2. ADATYA S, Naidu AS, Lee KK, Ambrosy AP, et al
   Enhancing Risk Stratification for Incident Systolic Heart Failure through Machine Learning and Natural Language Processing.
   Am Heart J. 2025 Sep 22:S0002-8703(25)00334-5. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. WANG J, Nouraie SM, Kelly NJ, Chan SY, et al
   Deep learning predicts cardiac output from seismocardiographic signals in heart failure.
   Am J Cardiol. 2025 Sep 30:S0002-9149(25)00593.
   PubMed         Abstract available
   
   
4. LIU B, Zhong Y, Yin X, Huang R, et al
   The Impact of Comorbidity Patterns on Clinical Outcomes in Heart Failure: A Machine Learning-Based Cluster Analysis.
   Am J Cardiol. 2025 Sep 28:S0002-9149(25)00598.
   PubMed         Abstract available
   
   
5. BUONO MGD, Saponara G, Sanna T
   Functional Capacity in Heart Failure: A Rising Tide Lifts All Boats.
   Am J Cardiol. 2025 Sep 26:S0002-9149(25)00581.
   PubMed        
   
   
6. PHERAI MS, de Jong FEI, Jansen J, Tukker M, et al
   Secondary Erythrocytosis in Patients with Heart Failure on SGLT2 inhibitors: Insights from a Multicenter "Real World" Study.
   Am J Cardiol. 2025 Sep 25:S0002-9149(25)00566.
   PubMed        
   
   
7. BUTT JH, Bundgaard JS, Schou M, Yafasova A, et al
   Implantable Cardioverter-Defibrillator And Frailty In Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Of The DANISH Trial.
   Am J Cardiol. 2025 Sep 23:S0002-9149(25)00577.
   PubMed         Abstract available
   
   
8. TAKEJI Y, Taniguchi T, Morimoto T, Shirai S, et al
   Early Aortic Valve Replacement Versus Clinical Surveillancein Asymptomatic Patients With Severe Aortic Stenosis.
   Am J Cardiol. 2025 Jun 7:S0002-9149(25)00360.
   PubMed         Abstract available
   
   
9. ADRICHEM R, Yang C, Geleijnse ML, van den Dorpel MMP, et al
   Transcatheter Aortic Valve Replacement for Patients with Moderate Aortic Stenosis - a Propensity Matched Analysis: TAVR vs clinical surveillance for moderate AS.
   Am J Cardiol. 2025 Jun 6:S0002-9149(25)00340.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

10. CLOTHIER JS, Kobsa S, Bojko M, Lester L, et al
    An Institutional Comparison of Patients Supported With Surgical vs Percutaneous Biventricular Assist Devices.
    Ann Thorac Surg. 2025;120:779-786.
    PubMed         Abstract available
    
    
11. HAWKINS RB, Stewart JW 2nd, Kim KD, Hou H, et al
    Association Between Left Ventricular Assist Device Infections and Number of Shared Patients Among Care Providers: A Network Analysis.
    Ann Thorac Surg. 2025;120:770-778.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

12. ELMORE G, Lohano SS, McVay NM, Levitan BM, et al
    RRAD-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failure.
    Cardiovasc Res. 2025 Oct 1:cvaf169. doi: 10.1093.
    PubMed         Abstract available
    
    
13. CHUNG B, Jonas W, Rostami F, Malik Z, et al
    Iron regulatory proteins secure iron availability in skeletal muscle to preserve exercise tolerance in heart failure.
    Cardiovasc Res. 2025 Sep 25:cvaf173. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Circ Res

14. BRITO-ESTRADA O, Kuwabara Y, Gibson AM, Hassel KR, et al
    DWORF Gene Therapy Improves Cardiac Calcium Handling and Mitochondrial Function.
    Circ Res. 2025;137:1072-1088.
    PubMed         Abstract available
    
    
15. YUCEL D, Ferreira de Araujo N, Souza-Neto F, Smith C, et al
    Septin4 Regulates Cardiac Fibrosis After Pressure Overload.
    Circ Res. 2025;137:1117-1132.
    PubMed         Abstract available
    
    
16. ELBATREEK MH, Lefer DJ
    Unlocking Mitochondrial Potential: DWORF to the Rescue in Heart Failure.
    Circ Res. 2025;137:1089-1091.
    PubMed        
    
    

    
    Circulation

17. REDEL-TRAUB G, Marx SO, Marks AR
    Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.
    Circulation. 2025;152:957-970.
    PubMed         Abstract available
    
    
18. PAN T, Lu L, Youker K, Shiau CK, et al
    Single-Cell Splicing Isoform Atlas of the Adult Human Heart and Heart Failure.
    Circulation. 2025 Sep 29. doi: 10.1161/CIRCULATIONAHA.125.074959.
    PubMed         Abstract available
    
    

    
    Eur Heart J

19. SEFEROVIC PM, Metra M, Mullens W
    Heart Failure 2025 Congress: a recent remarkable success in heart failure.
    Eur Heart J. 2025 Sep 26:ehaf619. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Heart Fail

20. FERREIRA JP, Vaduganathan M, Claggett BL, Kulac I, et al
    Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HF.
    Eur J Heart Fail. 2025 Oct 2. doi: 10.1002/ejhf.70052.
    PubMed         Abstract available
    
    
21. TAY WT, Teng TK, Ouwerkerk W, Cleland JGF, et al
    Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registry.
    Eur J Heart Fail. 2025 Oct 1. doi: 10.1002/ejhf.70056.
    PubMed         Abstract available
    
    
22. AIMO A, Codina P, Lee MMY, Tomasoni D, et al
    What's new in heart failure? August 2025.
    Eur J Heart Fail. 2025;27:1375-1378.
    PubMed        
    
    
23. MENTZ RJ, Butler J, McMullan CJ, Wojdyla DM, et al
    Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
    Eur J Heart Fail. 2025 Sep 29. doi: 10.1002/ejhf.70033.
    PubMed         Abstract available
    
    
24. COTTER G, Biegus J, Fudim M, Miro O, et al
    Acute heart failure care - a consensus series of an international experts' group.
    Eur J Heart Fail. 2025 Sep 28. doi: 10.1002/ejhf.70057.
    PubMed         Abstract available
    
    
25. GIGLI M, Verdonschot JAJ, Garcia-Pavia P, Stolfo D, et al
    Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC.
    Eur J Heart Fail. 2025 Sep 24. doi: 10.1002/ejhf.70042.
    PubMed         Abstract available
    
    
26. SEFEROVIC PM, Polovina M, Krejci J, Merkely B, et al
    Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey.
    Eur J Heart Fail. 2025 Sep 24. doi: 10.1002/ejhf.70031.
    PubMed         Abstract available
    
    
27. LUPI L, Antonioli E, Praderio A, Villaschi A, et al
    Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry.
    Eur J Heart Fail. 2025;27:1549-1558.
    PubMed         Abstract available
    
    
28. KANEKO T, Murata A, Amano M, Sato Y, et al
    Characteristics, determinants, and prognostic impact of severe tricuspid regurgitation in patients with atrial functional mitral regurgitation: Insights from the REVEAL-AFMR registry.
    Eur J Heart Fail. 2025;27:1539-1548.
    PubMed         Abstract available
    
    
29. NOUHRAVESH N, Gunn AH, Cyr D, Hernandez AF, et al
    Sacubitril/valsartan versus valsartan initiation in patients naive to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HF.
    Eur J Heart Fail. 2025;27:1418-1425.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

30. KASSAB VP, Oldra LGO, Milanesi GS, de Souza FR, et al
    Reply to "critical appraisal of early diagnosis and progression to heart failure with preserved ejection fraction among hypertensive patients with left ventricular hypertrophy".
    Int J Cardiol. 2025 Sep 26:133911. doi: 10.1016/j.ijcard.2025.133911.
    PubMed        
    
    
31. OKUMURA T, Hiraiwa H, Yanagisawa S, Takefuji M, et al
    Plasma proteomics and heart failure: A new frontier beyond ejection fraction.
    Int J Cardiol. 2025 Sep 30:133943. doi: 10.1016/j.ijcard.2025.133943.
    PubMed        
    
    

    
    J Am Coll Cardiol

32. PACKER M, Butler J, Lam CSP, Zannad F, et al
    Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
    J Am Coll Cardiol. 2025 Oct 1:S0735-1097(25)07501.
    PubMed         Abstract available
    
    
33. LEE H, Huang X, Khan SS, Son D, et al
    Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease.
    J Am Coll Cardiol. 2025;86:1017-1029.
    PubMed         Abstract available
    
    

    
    J Card Fail

34. BIERMANN HD, Speight CD, Montembeau SC, Mitchell AR, et al
    Qualitative Analysis of Patient-Physician Discussions About the Benefits and Tradeoffs of Heart Failure Medications.
    J Card Fail. 2025 Sep 22:S1071-9164(25)00375.
    PubMed         Abstract available
    
    
35. GORODESKI EZ, Shekhar S, Montgomery RA
    Match Decline Forecasts Slowing Advanced Heart Failure Cardiology Workforce Growth Toward 2030.
    J Card Fail. 2025 Sep 26:S1071-9164(25)00444.
    PubMed        
    
    
36. FUDIM M, Yaranov DM, Gupta R, Letarte L, et al
    Heart Failure Devices: Treatment Options, Underutilization, and a Proposed Trigger System for Patient Referral and Evaluation.
    J Card Fail. 2025 Sep 26:S1071-9164(25)00429.
    PubMed         Abstract available
    
    
37. LOPEZ J
    Between Two Signals: The Intersection of Electrophysiology and Heart Failure.
    J Card Fail. 2025 Sep 27:S1071-9164(25)00427.
    PubMed        
    
    
38. GOLOB S
    The Role of a Future Heart Failure Cardiologist in Expanding Access to Transplantation.
    J Card Fail. 2025 Sep 28:S1071-9164(25)00435.
    PubMed        
    
    
39. KHAN MS, Butler J, Karakas M, Placzek M, et al
    Intravenous Ferric Carboxymaltose in Ischemic Versus Non-Ischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2.
    J Card Fail. 2025 Sep 28:S1071-9164(25)00428.
    PubMed         Abstract available
    
    
40. SALAH HM, Ambrosy AP, Biegus J, Bocchi EA, et al
    Optimizing Pre- to Postdischarge Transition of Care in Patients Hospitalized for Heart Failure: Part 3 of the International Expert Opinion Series on Acute Heart Failure Management.
    J Card Fail. 2025 Sep 28:S1071-9164(25)00433.
    PubMed         Abstract available
    
    
41. FUDIM M, Mehra MR, Damman K, Uriel N, et al
    Derivation of a Personalized Congestion Score Using a Chronic Implantable Inferior Vena Cava Management System in Heart Failure: An Analysis from the FUTURE-HF Trial Portfolio.
    J Card Fail. 2025 Sep 28:S1071-9164(25)00430.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

42. OVERBEY DM, Kucera JA, Aykut B, Wolf SE, et al
    Pediatric Heart Transplant in Donation After Circulatory Death using Normothermic Regional Perfusion.
    J Thorac Cardiovasc Surg. 2025 Jun 20:S0022-5223(25)00535.
    PubMed         Abstract available
    
    

    
    PLoS One

43. LU M, Guo J, Yang P, Ma T, et al
    Insulin resistance markers HOMA-IR, TyG and TyG-BMI index in relation to heart failure risk: NHANES 2011-2016.
    PLoS One. 2025;20:e0331740.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.